BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31266653)

  • 1. Studying β
    Grisan F; Burdyga A; Iannucci LF; Surdo NC; Pozzan T; Di Benedetto G; Lefkimmiatis K
    Prog Biophys Mol Biol; 2020 Aug; 154():30-38. PubMed ID: 31266653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
    Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
    Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4B mediates local feedback regulation of β₁-adrenergic cAMP signaling in a sarcolemmal compartment of cardiac myocytes.
    Mika D; Richter W; Westenbroek RE; Catterall WA; Conti M
    J Cell Sci; 2014 Mar; 127(Pt 5):1033-42. PubMed ID: 24413164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.
    Bedioune I; Lefebvre F; Lechêne P; Varin A; Domergue V; Kapiloff MS; Fischmeister R; Vandecasteele G
    Cardiovasc Res; 2018 Sep; 114(11):1499-1511. PubMed ID: 29733383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-Dependent Maturation of iPSC-CMs Leads to the Enhanced Compartmentation of β
    Hasan A; Mohammadi N; Nawaz A; Kodagoda T; Diakonov I; Harding SE; Gorelik J
    Cells; 2020 Oct; 9(10):. PubMed ID: 33053822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes.
    Fu Q; Xu B; Parikh D; Cervantes D; Xiang YK
    Cell Signal; 2015 Mar; 27(3):707-15. PubMed ID: 25460042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation.
    Nikolaev VO; Moshkov A; Lyon AR; Miragoli M; Novak P; Paur H; Lohse MJ; Korchev YE; Harding SE; Gorelik J
    Science; 2010 Mar; 327(5973):1653-7. PubMed ID: 20185685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling.
    Wright PT; Nikolaev VO; O'Hara T; Diakonov I; Bhargava A; Tokar S; Schobesberger S; Shevchuk AI; Sikkel MB; Wilkinson R; Trayanova NA; Lyon AR; Harding SE; Gorelik J
    J Mol Cell Cardiol; 2014 Feb; 67():38-48. PubMed ID: 24345421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting FRET-Based Reporters for cAMP and PKA Activity Using AKAP79.
    Musheshe N; Lobo MJ; Schmidt M; Zaccolo M
    Sensors (Basel); 2018 Jul; 18(7):. PubMed ID: 29976855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
    Xiao RP
    Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling.
    Berthouze-Duquesnes M; Lucas A; Saulière A; Sin YY; Laurent AC; Galés C; Baillie G; Lezoualc'h F
    Cell Signal; 2013 Apr; 25(4):970-80. PubMed ID: 23266473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmentation of β
    Rudokas MW; Post JP; Sataray-Rodriguez A; Sherpa RT; Moshal KS; Agarwal SR; Harvey RD
    Br J Pharmacol; 2021 Apr; 178(7):1574-1587. PubMed ID: 33475150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling of beta-adrenergic receptors to cardiac L-type Ca2+ channels: preferential coupling of the beta1 versus beta2 receptor subtype and evidence for PKA-independent activation of the channel.
    Yatani A; Tajima Y; Green SA
    Cell Signal; 1999 May; 11(5):337-42. PubMed ID: 10376806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes.
    Bathe-Peters M; Gmach P; Boltz HH; Einsiedel J; Gotthardt M; Hübner H; Gmeiner P; Lohse MJ; Annibale P
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34088840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts.
    Fu Q; Xu B; Liu Y; Parikh D; Li J; Li Y; Zhang Y; Riehle C; Zhu Y; Rawlings T; Shi Q; Clark RB; Chen X; Abel ED; Xiang YK
    Diabetes; 2014 Aug; 63(8):2676-89. PubMed ID: 24677713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
    Chandrasekera PC; Wan TC; Gizewski ET; Auchampach JA; Lasley RD
    Cell Signal; 2013 Apr; 25(4):736-42. PubMed ID: 23291003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
    Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
    Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4.
    Richter W; Day P; Agrawal R; Bruss MD; Granier S; Wang YL; Rasmussen SG; Horner K; Wang P; Lei T; Patterson AJ; Kobilka B; Conti M
    EMBO J; 2008 Jan; 27(2):384-93. PubMed ID: 18188154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.